| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6241859 | Respiratory Medicine | 2014 | 22 Pages |
Abstract
MMF appears to offer no extra benefit to sarcoidosis patients unresponsive to previous steroid-sparing agents, but may be beneficial in patients intolerant to their previous steroid-sparing agent. Additional studies investigating the efficacy of MMF as the initial steroid-sparing agent are needed to further clarify the role of MMF in sarcoidosis.
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Nabeel Hamzeh, Allison Voelker, Anna Forssén, E. Brigitte Gottschall, Cecile Rose, Peggy Mroz, Lisa A. Maier,